← Leaderboards
Robert Y Tsai
Texas A&M University Health Science Ctr
$2,221,562
Attributed
$2,221,562
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $297K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,221,562 · 4
By mechanism
R01$1,246,850 · 1
R21$826,212 · 2
R03$148,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- Frederick Samuel Gimble$869,957
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsProgramsBaseSelf-RenewalMalignant NeoplasmsCancer CellResistanceDrug ResistanceNeoplasm MetastasisMalignant - DescriptorGrowthPropertyIn VivoNeoplastic CellPatternPharmaceutical PreparationsAblationCancer Stem CellDesignCellsBreastBreast Cancer CellPhenotypeStem
Grant awards (11)
Discovery of New DNA Methylation Biomarkers for Predicting the Malignant Outcome of Low-Grade Oral Dysplasia$189,981
R21 · FY2024 · DE · contact PI
Discovery of New DNA Methylation Biomarkers for Predicting the Malignant Outcome of Low-Grade Oral Dysplasia$227,856
R21 · FY2023 · DE · contact PI
Aging Effect on Genome Maintenance during Hepatocyte Regeneration$185,625
R21 · FY2017 · AG · contact PI
Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma$74,250
R03 · FY2017 · CA · contact PI
Aging Effect on Genome Maintenance during Hepatocyte Regeneration$222,750
R21 · FY2016 · AG · contact PI
Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma$74,250
R03 · FY2016 · CA · contact PI
Stem-like Cancer Cells in Breast Tumorigenesis$245,225
R01 · FY2009 · CA · contact PI
Stem-like Cancer Cells in Breast Tumorigenesis$245,225
R01 · FY2008 · CA · contact PI
Stem-like Cancer Cells in Breast Tumorigenesis$245,225
R01 · FY2007 · CA · contact PI
Stem-like Cancer Cells in Breast Tumorigenesis$252,549
R01 · FY2006 · CA · contact PI
Stem-like Cancer Cells in Breast Tumorigenesis$258,626
R01 · FY2005 · CA